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Staphylococcus aureus has long been recognized as one of the
major human pathogens and is responsible for a wide range
of diseases, from superficial skin infections to life-threatening
infections. The position of S. aureus as one of the most
important opportunistic human pathogens is largely attribut-
able to the combination of its virulence potential and its
ubiquitous occurrence as a colonizer in humans, domestic
animals, and livestock. Molecular typing allows several impor-
tant observations to be made regarding the evolution, epide-
miology and spread of S. aureus clones with particular public
health importance [1]. It appears that, over wide geographi-
cal regions, certain clones have emerged, disseminated, and
sometimes disappeared. It is speculated that clone histories
could result from the balance between occasional acquisition
or loss of virulence and/or antimicrobial resistance determi-
nants and selective pressure.
The best example concerns the epidemiology of methicil-
lin-resistant S. aureus (MRSA) clones. MRSA initially emerged
in Europe 40 years ago in the hospital setting, shortly after
the introduction of methicillin. During the mid-1980s, the
hospital-acquired MRSA (HA-MRSA) epidemic strains spread
to hospitals and healthcare facilities throughout the world
and became pandemic [2]. It was initially thought that the
HA-MRSA clone situation in hospitals was irreversible. How-
ever, they are not immovable, as indicated by a number of
observations of leading clones of HA-MRSA being replaced
by other clones [3]. Moreover, we recently observed, in
some European countries, a significant decline in HA-MRSA
prevalence, probably as a result of the implementation of
control measures against MRSA spread in hospitals [4].
However, MRSA is still a healthcare problem all over the
world because, during the past decade, the epidemiology of
MRSA has changed greatly, with the emergence of community-
onset MRSA infections. They are caused not only by HA-MRSA
strains that have been transferred from hospitals or healthcare
facilities into the community by patients or healthcare work-
ers, but also by a new generation of MRSA strains that are
genetically distinct form the HA-MRSA clones. In the first place
to community-associated MRSA (CA-MRSA) strains, which
have been isolated from people who have had little or no con-
tact with healthcare facilities or healthcare workers [5]. Such
strains have been detected in each continent, but they are
genetically diverse, and the most abundant CA-MRSA strains in
Europe are distinct from those in North America, Oceania, or
other parts of the world [6]. At this time, the most successful
CA-MRSA strain is USA300, which is now not only highly pre-
valent in the community in the USA, but is also invading hospi-
tals. Is USA300 now spreading over the world? This
information is provided in G. Nimmo’s review [7].
Concomitantly, new MRSA strains have been isolated
from livestock animals, particularly pigs and veal calves, in
countries where HA-MRSA and CA-MRSA are rare [8].
These livestock-associated MRSA strains were rapidly
detected in farm personnel, veterinarians, and slaughterhouse
personnel, suggesting that animals act as reservoirs of MRSA.
The process by which these strains emerged in the animal
population and subsequently in humans is still unclear. It is
believed that this is the consequence of the overuse and
consequent high selective pressure of antibiotics in livestock
animals, as suggested by the identification of genetic element
such as mecALGA251 and cfr that have not previously identified
in humans (see reviews by A. Fluit and Kadlec et al. [9,10]).
Although livestock-associated MRSA strains seem to be poor
colonizers of humans, sparse reports indicate that sequence
type 398 strains may acquire virulence factors that enable
them to colonize and infect new hosts [11]. The biggest
threat in this respect is further adaptation of sequence
type 398 to humans, because of its pandemic nature and the
huge reservoir of livestock animals. Therefore, future surveil-
lance studies are important to elucidate changes occurring in
the clonal distribution of MRSA and to design and evaluate
interventions to control MRSA spread.
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